Sun, Dec 28, 2014, 7:34 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • Tangible asset value = $1.58 per share

    Present value of future 10 year cash flows discounted at 9% = $6.30 per share

    Present value of future 10 year cash flows for pipeline adjusted statistically for probability of success = $16.50 per share.

    Value of Vertex = $24.38 per share

    So that is where the battle ground, if you use historical probabilities of clinical success of big pharma - you end up with a very low figure. If you assign a higher probability of success to the pipeline, you end up with a far higher number.

    What do you have in the near term to hold this up?

    Sell.

    Sentiment: Strong Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies